NASDAQ:IRTC

Irhythm Technologies Stock News

etoro logo Buy IRTC
*Your capital is at risk
$117.17
-1.91 (-1.60%)
At Close: Jul 31, 2026
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investig
Shares of iRhythm Technologies (NASDAQ: IRTC - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the fifteen research firms that are presently covering the company, Mark
iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of  iRhythm Technologies, Inc. (NASDAQ: IRTC) b
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Nov. 30, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inve
NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC)  brea
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies
New York, New York--(Newsfile Corp. - November 12, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NA
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies
New Heart Rhythm Journal publication and AHA 2025 data reinforce Zio LTCM clinical value and real-world evidence supporting proactive cardiac monitoring.
iRhythm Technologies stock has doubled this year.
SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict
Oppenheimer Asset Management Inc. reduced its position in iRhythm Technologies (NASDAQ: IRTC) by 40.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securit
AlphaQuest LLC grew its position in shares of iRhythm Technologies (NASDAQ: IRTC) by 344.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commissio
iRhythm Technologies Inc. (NASDAQ:IRTC) reported a third-quarter loss of 6 cents per share on Thursday, better than analysts' expectation of a 31-cent loss.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE